I ran BPC-157 subcu at the shoulder, 250mcg 2x/day for 4 weeks my second cycle. Shoulder got sore, which is why I switched. Totally understand that. But here’s what I couldn’t tell from just moving sites: was the soreness from the injection itself, or form three months of pressing volume wearing the joint down? BPC hyperlocal only helps if the actual problem is local tissue quality. If it’s training fatigue, switching to glutes won’t change that. What kind of soreness were you getting, sharp at the pin site or a dull overuse ache?
the local-vs-training-fatigue split is the right question, but there’s a third thing hiding in “sharp at the pin site.” subq at the shoulder is thin tissue, especially if the joint’s lost mass around it, and a shallow angle drops you intradermal without meaning to. that gives you an 8-10mm wheal that blanches, itches, warms up, gone by evening. reads like a soreness signal, it’s really placement. so before you decide it’s joint quality vs pressing volume, rule out depth and angle first, because that one’s mechanical and free to fix. dull overuse ache is the one that actually points at your training-fatigue question. sharp at the pin an hour later is usually the needle, not the tissue. ymmv.
1 Like
if you’re dropping intradermal, the wheal and itch overnight isn’t tissue damage - that’s just the needle track reacting. rule that out with proper depth, and the dull ache the next morning becomes your actual signal for whether it’s volume wearing the joint or placement.
The bit that lands hardest for me is “BPC hyperlocal only helps if the actual problem is local tissue quality.” That’s exactly the fork most people skip past, and you didn’t. Sorry the shoulder gave you grief, that pressing-volume question is the one I’d sit with before touching the site at all. Here’s what I’d add from my own logging. I ran two BPC cycles into a shoulder, both local subq, same 250mcg ballpark, and the thing I’d flag is that you switched at week 4. Week 4 is a hint, not a signal. The real depth on local BPC shows up in weeks 5 to 7 for me, so moving to glutes at the four-week mark didn’t just change the site, it reset your clock. Now you can’t tell whether the shoulder was about to turn the corner or whether it was training load all along. You changed the variable right at the point the data was about to get useful, which is a shame because everything else about how you’re thinking is sound. On the soreness question you asked him: sharp at the pin site reads as the injection, the volume or the bac water or just an unhappy bit of tissue, and it usually settles in a day or two. A dull overuse ache that tracks with your pressing days is the joint telling you about load, and no site change fixes that. fwiw I log pain on a 0 to 10 every few days against my training, and the days lined up before the sites ever did. For what it’s worth, across both my local cycles I logged nothing systemic, no gut changes, no mood shift, nothing. So if the problem really is training fatigue, glutes won’t reach it any better than the shoulder did. Worth getting bloods and a proper look before you blame the pin.
the “is it the pin or the pressing” question is the right one, but you can’t answer it after the fact either way. soreness that tracks injection days vs soreness that tracks heavy press days would split it, but only if you logged both with dates before you switched sites. switching to glutes mid-cycle also just added a variable, so even if the shoulder felt better after, you can’t tell if that’s the site or the three months of accumulated volume finally backing off on its own. the part i’d push on harder: “BPC hyperlocal only helps if the actual problem is local tissue quality.” even when it is local, you’ve got pressing load still moving underneath the whole run, so it’s not a clean tissue-quality test, it’s tissue quality plus ongoing mechanoload. three months of volume isn’t an acute injury on a clean clock, it arrives dysregulated and the loading hasn’t stopped. that’s a longer signal window than four weeks, and a stall at week 4 tells you basically nothing about the compound there.
the “wheal and itch overnight isn’t tissue damage” line is the part most people get wrong, so worth nailing down what it actually looks like. an intradermal bleb is an 8-10mm wheal that blanches when you press it, itches, runs a little warm, and is gone by evening. that whole pattern is mechanical. it’s the needle sitting too shallow, not the peptide and not the bac water. subq over a thin spot, and a repaired shoulder that’s lost some mass around it qualifies, overshoots intradermal real easy on a flat angle. so before anybody reformulates or blames a lot, check depth and angle first. a welt is data, an itch is just sensation, don’t let them collapse into one story. where i’d build on your point: the dull ache the next morning isn’t just a cleaner signal than the pin reaction, it’s also a better one than the peak soreness number. i stopped trusting “how bad did it get” a while back. what i track now is how fast it settles. a 5/10 that’s back to 3 by next morning when it used to linger two days is a function read you can’t really fool yourself into, where a single stair-climb score is noisy as hell. one thing that helped me actually capture that morning-after read instead of forgetting it by lunch: i log the ache score from the watch complication in the careclinic app, takes two seconds standing in the kitchen, and because it’s that low friction i actually do it every day instead of reconstructing the week from memory on sunday. the shape only shows up if you log consistently. on your original cycle, fwiw, four weeks of pressing volume plus a fresh pin site means you’ve got two things moving and the soreness could be either, which is exactly why the morning recovery curve matters more than the peak. if the ache is shrinking week over week regardless of site, that points at tissue. if it’s flat or growing, that’s your training fatigue talking and glutes won’t fix it. ymmv.
the “BPC hyperlocal only helps if the actual problem is local tissue quality” line is the part i keep coming back to, because it splits a confound most people log right past. i’m three weeks into bpc subq near a torn labrum, conservative dose, and the soreness question you’re asking is the exact one i can’t answer for myself either. mine reads more like a dull ache at the site than sharp pin pain, but here’s the thing, week 3 post soft tissue is also right when acute inflammatory load starts dropping on its own, training or not. so “it feels better around now” needs the same scrutiny as the site choice does. the sharp vs dull split you’re drawing is the right wedge though. sharp at the pin usually points at the needle or depth, dull overuse ache points at the joint doing its own thing under volume, and those want completely different responses. moving sites only fixes the first one. fwiw the part that muddies it for me is i can’t isolate the joint from everything else moving at once. my sleep went from like 4-5 fragmented hours to 6-7 solid over the same three weeks, rom’s up maybe 15 degrees overhead, pain down maybe 4 points on a 0-10. i genuinely can’t tell you how much of that is the peptide hitting local tissue vs just sleeping enough to let the shoulder recover from the pressing load you’re describing. if it was training fatigue wearing the joint down, better sleep alone would move the dial without the bpc doing a thing. not trying to argue your point, it lines up with mine, just adding that even once you sort sharp from dull you’ve still got the recovery-vs-repair confound sitting underneath. a compound acting on local tissue and a deload week can produce the same “shoulder feels better” log entry. logging soreness by type and not just intensity is the thing i wish i’d started on day one. sharp/dull/where, every dose. that’s the column that would actually answer your question. that’s my take.
the sharp-vs-dull split you’re asking him to make is the right diagnostic, but the sharp-at-pin-site branch isn’t one thing either. before you read it as the compound or the joint wearing down, isolate tonicity and depot formation. 250mcg 2x/day subq into a shoulder that’s already getting worked is a small volume going into undertreated tissue, and if the solution’s sitting off tissue osmolality you get a local inflammatory reaction that reads as pin-site soreness with zero bearing on whether the BPC is doing anything. that’s a rotation-and-dilution problem, not a site-choice one. minimum 12-14 days before you come back to the same spot, and run it more dilute. where I’d agree hard is the overuse branch. a dull ache from three months of pressing volume isn’t going to move because you went to glutes. and the part worth flagging is that BPC reaches the joint by diffusion across tissue planes regardless of pin site, so shoulder vs glute is doing less work than the framing assumes anyway. the bigger lever is the dosing gap, not the 2cm of placement. the actually diagnostic question isn’t shoulder vs glute, it’s whether you pulled pressing volume when you switched. if you didn’t, you changed two variables at once mid-cycle and can’t read either cleanly, and the ache is just tracking training load. ymmv, but I’d hold the protocol constant, deload the pressing, and see what soreness is left before crediting the site move with anything. as always, if the ache is sharp and localized into the joint itself rather than the tissue, that’s a get-it-looked-at thing, not a pin-site thing.
the “BPC hyperlocal only helps if the actual problem is local tissue quality” split is doing a lot of work, and i think you’re right that the soreness type is the tell. mine at the shoulder was a dull overuse ache, not sharp at the pin, which i read as the underlying labrum doing its own thing rather than the injection. one thing i’d add to your fatigue-vs-tissue question: there’s a third option underneath both. week 3 post-injury is roughly when acute inflammatory load starts dropping on its own regardless of what you’re running, so a soreness shift around then needs the same scrutiny before pinning it on the site choice. ngl that one keeps tripping me up.
before you split it between the pin and the pressing, third option nobody’s named: your diluent. benzyl alcohol concentration in BAC water isn’t standardized across vendors and it irritates subq more on repeat pins, so a dull ache that builds over a 4 week run can just be the water, not the joint or the volume.
the training-fatigue-vs-local-tissue split is the right question, and it’s the one most people skip straight past. where I’d push back is the “hyperlocal only helps if the problem is local” framing. subq at the shoulder isn’t depositing BPC into the joint, it’s diffusing across tissue planes, so the systemic fraction is in play regardless of where you pinned. that softens the shoulder-vs-glute distinction more than people assume. the bigger lever between your two cycles probably isn’t site at all, it’s whether the dosing schedule had gaps. a 2cm placement drift and a missed-day stretch are not the same class of variable, and the gap is the one that actually moves the curve. ymmv, but I’d isolate that before crediting the site change.
eta: one more thing
The local vs training-fatigue split is a clean frame, and you’re right that glutes won’t touch fatigue. but there’s a third thing it skips: you bailed at week 4. fwiw week 4 is a hint, not a signal on BPC, the real depth shows weeks 5-7. you want repeated exposure at the site, not a 4-week sprint you abandon the second it gets sore. so “shoulder got sore so I switched” might just be you pulling out before the window could discriminate between local tissue quality and overuse in the first place. also worth ruling out before you blame the joint, how’s your sleep been? disrupted sleep blunts remodeling, the repair symptoms get worse, worse joint wrecks the next night. that loop reads as “BPC isn’t working” when it’s actually the bed. ymmv.
worth flagging something underneath the local-vs-systemic split: a “sore shoulder” often isn’t one tissue. partial supraspinatus tear is tendon, reasonably vascular and load-responsive, so it’ll actually answer to hyperlocal BPC. but if there’s any labral involvement that’s fibrocartilage, largely avascular, and it heals badly to not at all regardless of where you pin or how clean your form gets. so a plateau you read as “site was wrong” or “training fatigue” can just be the avascular tissue’s ceiling showing through. two tissues on different clocks under one diagnosis. separate point on your subq question: there’s no depot to draw on either way. subq BPC clears in hours, so the soreness pattern you’re describing isn’t a slow tissue release thing, it’s either local irritation at the pin or the joint itself talking. fwiw the animal literature people cite for proximal delivery is about local concentration at the target, not systemic coverage, which is a different claim than most forum site-debates assume.
Worth separating two things that the “hyperlocal” framing quietly fuses: where you put the needle and where the compound actually ends up. Subq is still a systemic route. BPC-157’s measured plasma half-life in the rodent work is short, on the order of minutes, which is the part that complicates the whole “inject near the joint so it works on the joint” logic. If it clears that fast and distributes, then proximity to the shoulder is doing a lot less than people assume, and the glute-vs-shoulder question is mostly about injection comfort, not delivery. I haven’t seen human PK that resolves this, so anyone claiming the peptide “concentrates” at the pin site is reaching past the data. The other thing nobody’s flagged: almost the entire BPC-157 tendon and ligament literature is oral or IP dosing in rats, not local subq in lifters. So the dataset people cite to justify a site choice wasn’t built on site choice at all. If the real question is whether the compound is even reaching the tissue you care about, the site swap won’t tell you, because both sites feed the same systemic pool. The thing that would actually move your read is whether the soreness tracks the pin or tracks your pressing days, which is the question you already asked.
“site choice usually isn’t the real problem” is where I’d push back. The fatigue vs pin-soreness split is a fair question to chase, no argument there. But for BPC specifically, site isn’t a neutral knob. there’s actual debate in the literature about whether proximity to the injury matters for the local effect, so subq at the shoulder vs glute isn’t the same protocol, it’s two different exposure scenarios. moving sites to escape soreness might also be moving the compound away from where you wanted it working. so when you switched you changed two things at once: the soreness input and the proximity variable. if the glute run does less for the shoulder, you won’t know if that’s because the joint problem was training fatigue all along or because you pulled the dose off the target site. on the soreness itself, sharp at the pin usually reads more like volume or pH of the prep than overuse, but that’s a “ask whoever’s guiding your protocol” thing, not something i’d diagnose off a forum post. ymmv.
one thing nobody’s flagged: the sting itself can be the prep, not the tissue or the training. a lot of BPC ships as the acetate salt, and reconstituted in plain bac water it can sit acidic enough to burn subq, shoulder more than glute just because there’s less fat to buffer it. ymmv by vendor. if it’s sharp right at the pin and fades in a few min, that reads more like diluent pH than overuse. worth noting separately from your local-vs-fatigue question, and easy to rule out by tightening rotation and mapping for lumps before you blame the site.
track site soreness versus joint pain daily, that’s the only way
That’s a tough spot to be in, trying to untangle two different kinds of soreness. The question you’re asking, whether it’s the pin or “three months of pressing volume wearing the joint down,” is the whole ballgame. You’re right that if the problem is just accumulated training fatigue, moving the injection site won’t fix the underlying issue. But I wouldn’t dismiss the site choice entirely.
For BPC specifically, there’s a real debate in the studies about whether proximity to the injury actually helps. It’s one of the main variables people argue about. The other piece is whether you changed your training load at the same time. If you deloaded your pressing while you were pinning near the shoulder, that’s another variable in the mix.
You can’t know if it was the BPC or just giving the joint a break that helped. Deloads heal tissue too. fwiw.
distinguishing between injection site pain and actual joint pain is proper tricky, i’ve had the same with my wrist. but your “three months of pressing volume wearing the joint down” isn’t one thing, it could be
It’s genuinely hard to separate those two sensations out in real time, isn’t it? The difference between a true local tissue issue and general training load soreness gets blurred when you’re also adding an injection reaction, and